Perceptive Advisors’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-885,818
| Closed | -$21.8M | – | 155 |
|
|
2021
Q3 | $21.8M | Sell |
885,818
-193,210
| -18% | -$4.76M | 0.32% | 66 |
|
|
2021
Q2 | $26.7M | Sell |
1,079,028
-20,000
| -2% | -$494K | 0.35% | 68 |
|
|
2021
Q1 | $24M | Sell |
1,099,028
-136,790
| -11% | -$2.98M | 0.3% | 69 |
|
|
2020
Q4 | $31.5M | Hold |
1,235,818
| – | – | 0.34% | 61 |
|
|
2020
Q3 | $34.8M | Hold |
1,235,818
| – | – | 0.51% | 51 |
|
|
2020
Q2 | $31.6M | Buy |
+1,235,818
| New | +$31.6M | 0.51% | 47 |
|